Skip to main content
. 2017 Jun 6;7:2883. doi: 10.1038/s41598-017-02889-5

Table 2.

Ratio of plasma and faecal bile acid content in relation to BL group.

PLASMA FAECES
HFD HFD + P HFD HFD + P
Total bile acids 1.39 ± 0.56 1.07 ± 1.20 1.72 ± 0.34* 2.30 ± 0.49***#
Conjugated bile acids 1.56 ± 1.13 0.90 ± 0.57 2.07 ± 1.21 3.62 ± 2.96*
Unconjugated bile acids 1.35 ± 0.48 1.11 ± 1.46 1.71 ± 0.33* 2.27 ± 0.46***#
Individual bile acids
Ursocholanic Acid ND ND 1.16 ± 0.44 1.32 ± 0.47
3-Ketocholanic Acid ND ND 1.12 ± 0.51 1.39 ± 0.70
Lithocholic acid ND ND 1.11 ± 0.33 1.25 ± 0.46
Allolithocholic Acid ND ND 1.38 ± 0.65 1.98 ± 1.08
Isolithocholic Acid ND ND 1.11 ± 0.55 1.22 ± 0.55
3,6/12-Diketocholanic Acid ND ND 0.94 ± 0.80 1.58 ± 1.04
3α-Hydroxy-12 Ketolithocholic Acid ND ND 1.74 ± 0.61 2.47 ± 0.87*
Deoxycholic Acid/Chenodeoxycholic ND ND 1.29 ± 0.17 1.68 ± 0.28*p=0.052
5β-Cholanic Acid-3β, 12α-diol ND ND 0.94 ± 0.23 1.17 ± 0.37
Murocholic Acid ND ND 3.07 ± 1.77** 4.83 ± 2.54***
Ursodeoxycholic acid ND ND 1.58 ± 0.11* 2.31 ± 0.36**##
Hyodeoxycholic acid ND ND 2.26 ± 0.91** 4.42 ± 1.91***#
12-Dehydrocholic Acid 0.59 ± 0.27 0.59 ± 0.78 2.41 ± 1.09* 2.58 ± 1.29*
ω-Muricholic Acid 0.93 ± 0.32 0.59 ± 0.77 1.87 ± 0.39** 2.22 ± 0.46**
α/β-Muricholic acid 2.41 ± 0.99 1.94 ± 2.49 2.98 ± 1.19*** 4.28 ± 1.29***
Hyocholic acid ND ND 1.20 ± 0.38 1.67 ± 0.43
Cholic acid 1.49 ± 0.63 1.35 ± 1.82 17.00 ± 16.70 18.82 ± 15.33***
Taurochenodeoxycholic Acid 9.18 ± 9.09* 4.36 ± 3.04 2.99 ± 1.32* 8.40 ± 5.75***#
Taurodeoxycholic Acid 1.08 ± 0.88 0.86 ± 0.53 6.12 ± 4.21** 13.75 ± 13.81***
Tauro-ursodeoxycholic Acid 1.50 ± 0.26 1.16 ± 0.66 3.88 ± 2.51* 6.25 ± 4.50**
Taurohyodeoxycholic Acid ND ND 2.73 ± 1.50* 7.25 ± 5.46**
Taurocholic Acid 0.88 ± 0.82 0.50 ± 0.43 0.60 ± 0.22 1.29 ± 1.08
Tauro-ω,α,β Muricholic Acid 1.99 ± 1.27 1.04 ± 0.62 2.70 ± 1.76 3.64 ± 2.64**

Data represent the means ± SD of 4 (plasma) or 6 (faeces) mice per group. Values of p were determined using one-way ANOVA with Tukey’s (equal variance) or Dunnett’s T3 (unequal variance) post-hoc analysis where p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the BL group; # p < 0.05, ## p < 0.01, and ### p < 0.001 versus the HFD group. Values of p compared to the HFD group are stated where appropriate. ND, not detected.

HHS Vulnerability Disclosure